|
PPP2R3C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.14044362631694E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.59186030812953E-12 |
| Normal-vs-Stage2 |
1.227400E-04 |
| Normal-vs-Stage3 |
1.94130000963355E-09 |
| Normal-vs-Stage4 |
1.352760E-04 |
| Stage1-vs-Stage2 |
1.101400E-01 |
| Stage1-vs-Stage3 |
9.376200E-01 |
| Stage1-vs-Stage4 |
6.913600E-01 |
| Stage2-vs-Stage3 |
1.282770E-01 |
| Stage2-vs-Stage4 |
5.088000E-01 |
| Stage3-vs-Stage4 |
6.494000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.97609714650093E-11 |
| Normal-vs-AfricanAmerican |
2.13789996816871E-09 |
| Normal-vs-Asian |
5.645900E-04 |
| Caucasian-vs-AfricanAmerican |
7.079000E-01 |
| Caucasian-vs-Asian |
9.871800E-01 |
| AfricanAmerican-vs-Asian |
9.021400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.60724775102972E-12 |
| Normal-vs-Female |
6.4813999944846E-08 |
| Male-vs-Female |
5.722200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.25080001911471E-09 |
| Normal-vs-Extreme_Weight |
1.34029998211105E-09 |
| Normal-vs-Obese |
8.06109956563716E-10 |
| Normal-vs-Extreme_Obese |
1.89100000003162E-06 |
| Normal_Weight-vs-Extreme_Weight |
5.831000E-01 |
| Normal_Weight-vs-Obese |
3.151000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.715200E-01 |
| Extreme_Weight-vs-Obese |
6.293600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.496600E-01 |
| Obese-vs-Extreme_Obese |
3.447400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.82589999997429E-06 |
| Normal-vs-Age(41-60Yrs) |
3.38580052883231E-10 |
| Normal-vs-Age(61-80Yrs) |
1.45120027106316E-10 |
| Normal-vs-Age(81-100Yrs) |
1.39950000033195E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.376400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.021200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.544650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.872200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.569650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.427800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.72972747236599E-12 |
| Normal-VS-Type2 PRCC |
9.22239951073323E-10 |
| Normal-VS-KIRP CIMP |
1.68567999999647E-05 |
| Normal-VS-Unclassified PRCC |
1.87770000004139E-06 |
| Type1 PRCC-VS-Type2 PRCC |
9.135400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.950000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.169200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.579200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.799600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.028400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.71529998275133E-09 |
| Normal-vs-N1 |
1.04629999997385E-07 |
| Normal-vs-N2 |
2.31139999995467E-06 |
| N0-vs-N1 |
9.803400E-01 |
| N0-vs-N2 |
7.463900E-02 |
| N1-vs-N2 |
5.028300E-02 |
|
|
